Evidence map›Paper›PMID 32588988›Full record

SynthesisMolecular genetics & genomic medicine2020

Systematic summarization of the expression profiles and prognostic roles of the dishevelled gene family in hepatocellular carcinoma.

Jie Mei, Xuejing Yang, Dandan Xia, Weijian Zhou, Dingyi Gu, Huiyu Wang, Chaoying Liu

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Molecular genetics & genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Spaceflight alters host-gut microbiota interactions.NPJ biofilms and microbiomes · 2024
    Article
  7. DNA methylation alterations caused byFrontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jie MeiDepartment of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Xuejing YangDepartment of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Dandan XiaDepartment of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Weijian ZhouDepartment of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Dingyi GuDepartment of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Huiyu WangDepartment of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Chaoying LiuDepartment of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.ORCID 0000-0003-0484-9522
Wuxi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDishevelled (DVL) family members are crucial to Wnt-induced signaling transduction, and their expression is highly correlated with the progression of multiple malignant cancers. However, the expression profiles and exact prognostic values of DVLs in hepatocellular carcinoma (HCC) have not been explored until now.

methodsThe expression of DVL isoforms was assessed using the Oncomine, HCCDB and UALCAN databases. The prognostic roles of DVLs were further evaluated using the GEPIA database. The relationship between the expression of DVLs and immune infiltration of HCC was investigated using the Timer and ImmuCellAI tools. Furthermore, protein-protein interaction (PPI) networks were built and enrichment analyses were conducted.

resultsWe found that the expression levels of DVL2 (OMIM accession number: 602151) and DVL3 (OMIM accession number: 601368) were upregulated in HCC tissues as revealed by the Oncomine and HCCDB databases. Additionally, the expression of DVLs tended to be associated with advanced clinical features in the UALCAN database. Prognostic analysis revealed that the expression levels of DVL1 (OMIM accession number: 601365) and DVL3 were remarkably associated with a poor prognosis in HCC patients. The results also revealed that the DVL expression level was correlated with the infiltration levels of multiple immune cells. By constructing the PPI network and enrichment analyses, the DVL1-3 gene was identified to interact with 20 key genes and participate in several pathways.

conclusionIn summary, DVL2 and DVL3 are highly expressed in HCC, and DVL1 and DVL3 are related to a poor prognosis, which might be used as candidate targets for targeted therapy and reliable prognostic biomarkers in HCC.

Indexed as

Biomarkers, TumorCarcinoma, HepatocellularDatabases, GeneticDishevelled ProteinsGene Expression Regulation, NeoplasticHumansLiver NeoplasmsUp-RegulationBiomarkers, TumorDishevelled ProteinsDVL2 protein, humanbioinformaticsdishevelledgene expressionhepatocellular carcinoma

Identifiers

PMID32588988
PMCPMC7507050
OpenAlexW3037495381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.